Cigna Group (CI) Projected to Post Earnings on Thursday

Cigna Group (NYSE:CI) is expected to be posting its Q1 2026 results before the market opens on Thursday, April 30th. Analysts expect Cigna Group to post earnings of $7.57 per share and revenue of $66.8922 billion for the quarter. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Individuals are encouraged to explore the company’s upcoming Q1 2026 earning overview page for the latest details on the call scheduled for Thursday, April 30, 2026 at 8:30 AM ET.

Cigna Group (NYSE:CI) last released its earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, beating the consensus estimate of $7.88 by $0.20. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The firm had revenue of $72.50 billion during the quarter, compared to analyst estimates of $69.53 billion. During the same quarter in the previous year, the firm earned $6.64 earnings per share. The firm’s revenue for the quarter was up 10.4% compared to the same quarter last year. On average, analysts expect Cigna Group to post $30 EPS for the current fiscal year and $33 EPS for the next fiscal year.

Cigna Group Stock Up 2.5%

CI stock opened at $282.43 on Tuesday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.74 and a quick ratio of 0.74. Cigna Group has a 1-year low of $239.51 and a 1-year high of $350.00. The firm has a fifty day moving average price of $274.32 and a two-hundred day moving average price of $276.85. The firm has a market cap of $74.43 billion, a price-to-earnings ratio of 12.73, a PEG ratio of 0.95 and a beta of 0.26.

Cigna Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th will be paid a dividend of $1.56 per share. The ex-dividend date is Thursday, June 4th. This represents a $6.24 annualized dividend and a yield of 2.2%. Cigna Group’s payout ratio is presently 28.13%.

Analyst Ratings Changes

CI has been the subject of several recent research reports. Robert W. Baird lowered their target price on shares of Cigna Group from $315.00 to $306.00 and set an “outperform” rating for the company in a research note on Wednesday, April 15th. TD Cowen boosted their target price on shares of Cigna Group from $333.00 to $338.00 and gave the company a “buy” rating in a research note on Monday, February 9th. Sanford C. Bernstein upgraded shares of Cigna Group from a “market perform” rating to an “outperform” rating and boosted their target price for the company from $307.00 to $358.00 in a research note on Thursday, March 12th. Deutsche Bank Aktiengesellschaft boosted their target price on shares of Cigna Group from $301.00 to $304.00 and gave the company a “buy” rating in a research note on Tuesday, February 10th. Finally, Zacks Research upgraded shares of Cigna Group from a “strong sell” rating to a “hold” rating in a research note on Monday, January 5th. One research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $332.47.

Insider Activity

In other news, insider Nicole S. Jones sold 2,307 shares of the company’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $666,515.37. Following the completion of the transaction, the insider owned 32,647 shares in the company, valued at approximately $9,432,044.77. This represents a 6.60% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Everett Neville sold 1,719 shares of the company’s stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $496,636.29. Following the transaction, the insider owned 5,670 shares of the company’s stock, valued at $1,638,119.70. This represents a 23.26% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.60% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Cigna Group

Several institutional investors have recently modified their holdings of the company. State Street Corp grew its position in shares of Cigna Group by 1.8% during the fourth quarter. State Street Corp now owns 12,339,250 shares of the health services provider’s stock worth $3,396,132,000 after acquiring an additional 224,122 shares during the last quarter. Dodge & Cox lifted its holdings in Cigna Group by 19.7% in the fourth quarter. Dodge & Cox now owns 11,138,614 shares of the health services provider’s stock worth $3,065,681,000 after purchasing an additional 1,833,389 shares during the period. GQG Partners LLC lifted its holdings in Cigna Group by 14.3% in the fourth quarter. GQG Partners LLC now owns 7,763,295 shares of the health services provider’s stock worth $2,136,699,000 after purchasing an additional 972,302 shares during the period. Invesco Ltd. lifted its holdings in Cigna Group by 27.4% in the fourth quarter. Invesco Ltd. now owns 2,421,775 shares of the health services provider’s stock worth $666,545,000 after purchasing an additional 521,273 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in Cigna Group by 1.0% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,325,173 shares of the health services provider’s stock worth $639,957,000 after purchasing an additional 23,202 shares during the period. Institutional investors own 86.99% of the company’s stock.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.